RECENT ADVANCES IN THE SYNTHESIS AND PHARMACOLOGICAL APPLICATIONS OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS

We focused in this review paper the Nitrogen-containing heterocyclic compounds represent a fundamental class of molecules in medicinal chemistry and drug discovery due to their remarkable structural diversity and broad spectrum of biological activities. These scaffolds are widely present in natural products, pharmaceuticals, and numerous bioactive molecules, largely because their heteroatomic frameworks facilitate strong interactions with biological targets. Consequently, nitrogen-containing heterocycles have become key structural motifs in many therapeutically important drugs. Over the past decade, significant advances in synthetic methodologies have expanded the accessibility and diversity of nitrogen-rich heterocyclic frameworks. Modern synthetic strategies including transition-metal catalysis, multicomponent reactions, microwave-assisted synthesis, and green chemistry approaches have enabled the efficient and selective construction of complex heterocyclic architectures. Alongside these developments, structure activity relationship (SAR) studies and computational approaches have played a crucial role in guiding the rational design and optimization of biologically active derivatives with enhanced efficacy and selectivity. Despite these advances, several challenges remain in the development of heterocyclic compounds as therapeutic agents, including toxicity concerns, unfavorable pharmacokinetic properties, and difficulties associated with scalable synthesis. In this context, the present review provides a comprehensive overview of recent developments in the synthesis, structural diversity, and pharmacological significance of nitrogen-rich heterocyclic scaffolds. Particular emphasis is placed on emerging synthetic methodologies, biological activities, and computational strategies that support modern drug design. Additionally, current challenges and future perspectives are discussed to highlight the potential of nitrogen-containing heterocyclic scaffolds as promising candidates for next-generation therapeutic agents.